Adaptive Biotechnologies (ADPT) Inventory (2018 - 2026)

Adaptive Biotechnologies has reported Inventory for 9 years, with the latest figure at $11.2 million in Q1 2026.

• Quarterly Inventory rose 29.04% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (up 29.04% YoY) and the FY2025 annual result came in at $9.8 million, up 16.35% from the prior year.
• Inventory grew to $11.2 million in Q1 2026 per ADPT's latest filing, from $9.8 million in the prior quarter.
• Over five years, Inventory peaked at $21.0 million in Q1 2022 and troughed at $8.4 million in Q2 2025.
• A 5-year average of $14.1 million and a median of $13.3 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2026: Inventory sank 41.58% in 2024, then rose 29.04% in 2026.
• Over 5 years, Inventory stood at $14.5 million in 2022, then declined by 0.03% to $14.4 million in 2023, then plunged by 41.58% to $8.4 million in 2024, then gained by 16.35% to $9.8 million in 2025, then climbed by 14.11% to $11.2 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $11.2 million, $9.8 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.